The partnership is intended to support the infrastructure, compliance, and innovation in the industry.
Image | adobe.stock/darren415
In a March 11, 2025, press release (1), cannabis industry investment firm Poseidon Investment Management announced it was partnering with Würk and with C15 Solutions. Using a diversified strategy, Poseidon currently provides capital to 29 companies.
The human capital company Würk assists cannabis businesses with payroll, human resources, timekeeping, scheduling, and tax compliance, offering direction with 280E tax law, accounting, and compliant banking. Technology vendor C15 Solutions provides a customized 'electronic Quality Management System' (eQMS) to improve cannabis products’ consistency and safety while striving to keep the cost of quality low.
The two companies will operate separately in the partnership, though together they have a combined 15 years of experience of assisting cannabis businesses with human capital management and industry regulations. With Poseidon’s support, the new partnership is intended to provide cannabis business more tools and expertise for better regulatory compliance and workforce management, helping to navigate the ever-changing industry. The goal will be to improve efficiency and generate growth for companies.
"Collaboration is essential to achieving and sustaining long-term solutions in our rapidly evolving industry," stated Poseidon Co-founder and Managing Director Morgan Paxhia, in the press release. "C15 Solutions and Würk's partnership reflects our commitment to strengthening the ancillary cannabis network by building connections that fuel industry growth and enhance operational excellence. We look forward to being a teammate to emerging cannabis companies pushing boundaries, fostering innovating, and looking to grow."
In December 2024, Poseidon announced it had completed two investments in the New Jersey dispensaries BLKBRN and Dogwood Green, which were set to open in 2025 and intended to serve both medical cannabis patients and recreational use (2). "With these two investments, we are allocating to retail in special situations, driving outsized sales with a focus on profitability, increasing the probability of success for founders, and generating faster returns for our investors," Poseidon Managing Director, Patrick Rea had stated in a press release. New Jersey is one of the fastest growing cannabis markets, the press release also stated.
Additionally, one of Poseidon’s portfolio companies, Distru, secured $6 million in series a funding in November 2024 (3). The seed-to-sale ERP platform serves operators across 25 states and assists with consolidating operations, including inventory management, order workflows, and analytics. Its goal is to become central to cannabis businesses, supporting regulatory compliance, and growth.
"Distru's clear focus on supporting cannabis operators' success and compliance, coupled with a robust and scalable platform, aligns with our commitment to backing transformative solutions in the sector. They have built the best in class Cannabis ERP and we see that advantage compounding over time," said Morgan Paxhia, in the press release.
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.